Rinvoq ER 30 MG tablet UU 30S

Ended Awarded

Contract number
SPE2DR26FT3SR
Awardee
Awarding agency
Obligated
$9,419

Award facts

Contract value 100% obligated
$9,418.64 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $9,418.64 delivery order to Amerisourcebergen Drug Corp on July 14, 2026, for RINVOQ ER 30 mg tablets (30-count unit of use).

Place of performance is Conshohocken, PA. The order has a firm fixed-price structure with an ultimate completion date of July 15, 2026. No set-aside was applied. The awardee is a pharmaceutical distributor and subsidiary of Cencora, Inc., supplying brand-name and generic medications, specialty pharmaceuticals, and medical devices to Defense Health Agency and military medical facilities globally under the DLA Troop Support Medical indefinite delivery contract program.

Quick answers

Who was awarded contract SPE2DR26FT3SR?

SPE2DR26FT3SR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 14, 2026.

How much is contract SPE2DR26FT3SR worth?

The government has obligated $9,419 on SPE2DR26FT3SR.

Is contract SPE2DR26FT3SR an order under another contract?

Yes. SPE2DR26FT3SR is a delivery order under SPE2DR25D3109, an indefinite delivery contract.

Was contract SPE2DR26FT3SR competed?

The extent of competition for SPE2DR26FT3SR was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award